LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 39 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -62.5% | 11,768 | -46.7% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 22,096 | +75.9% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 12,561 | +316.8% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 3,014 | +163.2% | 0.00% | – |
| Q3 2021 | $5,000 | -68.8% | 1,145 | -68.3% | 0.00% | – |
| Q2 2021 | $16,000 | -30.4% | 3,610 | +14.9% | 0.00% | – |
| Q1 2021 | $23,000 | +53.3% | 3,143 | +62.3% | 0.00% | – |
| Q4 2020 | $15,000 | -86.1% | 1,936 | -83.7% | 0.00% | -100.0% |
| Q3 2020 | $108,000 | +535.3% | 11,913 | +500.8% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +54.5% | 1,983 | -11.8% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | -45.0% | 2,249 | +47.7% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | +233.3% | 1,523 | +150.1% | 0.00% | – |
| Q1 2019 | $6,000 | – | 609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,290,000 | 0.43% |
| Orbimed Advisors | 8,466,783 | $38,778,000 | 0.43% |
| Sio Capital Management, LLC | 182,630 | $836,000 | 0.27% |
| Eversept Partners, LP | 349,919 | $1,602,629 | 0.11% |
| SAMLYN CAPITAL, LLC | 1,474,108 | $6,752,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $1,467,000 | 0.04% |
| PURA VIDA INVESTMENTS, LLC | 245,492 | $1,124,000 | 0.03% |
| SANDERS MORRIS HARRIS LLC | 35,000 | $160,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 176,500 | $808,000 | 0.02% |
| Ergoteles LLC | 65,827 | $301,000 | 0.01% |